Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01743339 · ClinicalTrials.gov registry record · NA
Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01743339: Completed NA study, sponsored by University of Rochester.
NCT01743339 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01743339, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The primary purpose of this study is to test whether and how cognitive-behavioral therapy for insomnia (CBTi), a well-supported and highly effective insomnia treatment, may directly improve Posttraumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) symptoms. The study is designed as a randomized controlled trial (RCT) to test the effect of CBTi on symptoms of PTSD and co-morbid depression prior to an evidence-based PTSD intervention and to assess the role of neurobiological processes and sleep architecture in mediating treatment outcomes.
Primary Outcome
The Clinician Administered PTSD Scale (CAPS)will be used as our primary PTSD outcome measure.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-02 |
| Phase | NA |
What the finished NCT01743339 record still lists
NCT01743339 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT01743339 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01743339 about?
NCT01743339 is a clinical study titled "Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress". The primary purpose of this study is to test whether and how cognitive-behavioral therapy for insomnia (CBTi), a well-supported and highly effective insomnia treatment, may directly improve Posttraumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) symptoms. The study is designed as a ...
What is the current status of trial NCT01743339?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2013-01. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01743339?
The interventions under investigation include: Control (BEHAVIORAL), Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01743339?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01743339's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia